Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Tigilanol tiglate |
Synonyms | |
Therapy Description |
Tigilanol tiglate is a diterpene ester that activates protein kinase C, potentially resulting in increased tumor cell death and reduced tumor growth (PMID: 25272271, PMID: 33420238). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Tigilanol tiglate | EBC-46|EBC 46|EBC46|EBI 46|EBI-46|EBI46 | Tigilanol tiglate is a diterpene ester that activates protein kinase C, potentially resulting in increased tumor cell death and reduced tumor growth (PMID: 25272271, PMID: 33420238). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05608876 | Phase II | Tigilanol tiglate | A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer | Recruiting | GBR | AUS | 0 |
NCT05755113 | Phase II | Tigilanol tiglate | A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma | Recruiting | USA | 0 |
NCT05234437 | Phase II | Tigilanol tiglate | A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma | Terminated | AUS | 0 |